Skip to main content

Table 1 Clinical characteristics of the subjects

From: GLUT3-mediated cigarette smoke-induced epithelial-mesenchymal transition in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway

 

Gender

Age

Smoking history (pack-years)

FEV1 (%) predicted

FEV1/FVC (%)

GOLD stages

Non smoker-1

male

46

106.9

87.39

Non smoker-2

male

51

72.8

86.48

Non smoker-3

male

79

90.4

83.17

Non smoker-4

male

60

80.5

92.44

Non smoker-5

male

58

82.5

80.07

Non smoker-6

male

63

81.6

86.75

Non smoker-7

male

65

81.4

98.44

Non smoker-8

male

72

74.9

72.76

Smoker-1

male

65

30

80.29

73.01

Smoker-2

male

53

30

118.1

84.81

Smoker-3

male

51

30

106.9

83.61

Smoker-4

male

69

40

119.8

86.77

Smoker-5

male

70

50

59.5

72.41

Smoker-6

male

70

45

87.2

92.62

Smoker-7

male

55

20

101.6

73.36

Smoker-8

male

76

20

86.6

83.27

COPD Smoker-1

male

77

40

46.2

52.73

 

COPD Smoker-2

male

64

20

80.2

68.63

 

COPD Smoker-3

male

63

40

85.3

62.01

 

COPD Smoker-4

male

63

40

44.1

51.99

 

COPD Smoker-5

male

79

40

26.6

29.49

 

COPD Smoker-6

male

66

30

32.3

38.04

 

COPD Smoker-7

male

66

35

46.5

36.44

 

COPD Smoker-8

male

77

60

28.6

48.62

 
 

Non Smoker

Smoker

COPD

Number

8

8

8

Sex, male

8(100%)

8(100%)

8(100%)

Age, years

61.75±10.66

63.6±9.3

69.4±7.0

Smoking history, pack-years

33.1±11.0

38.1±11.3

FEV1 (%) predicted

83.88±10.69

95.0±20.5

48.7±22.4

FEV1/FVC (%)

85.9±7.7

81.2±7.5

48.5±13.3

  1. Data are presented as means ± SD, unless otherwise stated